Bevacizumab

Bevacizumab Reactions 1680, p68 - 2 Dec 2017 Aggravation of cerebral radiation necrosis: case report In a study, a 53-year-old woman was described who developed aggravation of cerebral radiation necrosis (CRN) following the administration of bevacizumab [route not stated]. The woman with a history of brain metastasis of lung adenocarcinoma was treated with stereotactic radiotherapy. She was diagnosed with CRN in September 2012. From December 2012 to July 2013, she received 10 cycles of bevacizumab. During the treatment, her condition had resolved markedly. Nonetheless, in June 2014, the CRN recurred. From October 2014 to March 2015, she was scheduled to receive seven cycles of bevacizumab 5 mg/kg every three to four weeks. In March 2015, a re-examination demonstrated aggravation of CRN instead of reduction. The woman’s treatment with bevacizumab was discontinued. In September 2015, the CRN exhibited local resolution and dissipation. Author comment: "Long time bevacizumab medications cause blood vessels over trimming, and the CRN aggravation." "The lesion was significantly reduced after discontinuation." Zhuang H, et al. Indication of bevacizumab for cerebral radiation necrosis. Recent Patents on Anti-Cancer Drug Discovery 12: 272-277, No. 3, 2017. Available from: URL: http://doi.org/10.2174/1574892812666170425124430 - China 803285422 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Bevacizumab

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/bevacizumab-7RkjGMVJe0
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-38999-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p68 - 2 Dec 2017 Aggravation of cerebral radiation necrosis: case report In a study, a 53-year-old woman was described who developed aggravation of cerebral radiation necrosis (CRN) following the administration of bevacizumab [route not stated]. The woman with a history of brain metastasis of lung adenocarcinoma was treated with stereotactic radiotherapy. She was diagnosed with CRN in September 2012. From December 2012 to July 2013, she received 10 cycles of bevacizumab. During the treatment, her condition had resolved markedly. Nonetheless, in June 2014, the CRN recurred. From October 2014 to March 2015, she was scheduled to receive seven cycles of bevacizumab 5 mg/kg every three to four weeks. In March 2015, a re-examination demonstrated aggravation of CRN instead of reduction. The woman’s treatment with bevacizumab was discontinued. In September 2015, the CRN exhibited local resolution and dissipation. Author comment: "Long time bevacizumab medications cause blood vessels over trimming, and the CRN aggravation." "The lesion was significantly reduced after discontinuation." Zhuang H, et al. Indication of bevacizumab for cerebral radiation necrosis. Recent Patents on Anti-Cancer Drug Discovery 12: 272-277, No. 3, 2017. Available from: URL: http://doi.org/10.2174/1574892812666170425124430 - China 803285422 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off